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Abstract 
Tween 80-span 80 based organogels were prepared by fluid-filled structure mechanism by 
varying the composition of the organogels. The microstructures of the organogels were 
studied by light microscopy. The organogels were subjected to the accelerated stability test 
and time dependent stability test. The stable organogels were characterized by XRD, FTIR, 
and simultaneous DTA-TGA, pH and dc impedance measuring devices. Salicylic acid (model 
drug) was incorporated within the organogels and its release properties from the organogel 
matrices were studied. The antimicrobial efficiency of the salicylic loaded product was tested 
against Bacillus subtilis. The organogels were analyzed for biocompatibility using hemolysis 
studies. The microscopic studies indicated fluid-filled globular structures forming the gelled 
structures. The stability and the properties were found to be dependent on the proportion of 
the surfactant mixture (SM) and water. In general, when the ratio of SM: water was in the 
range of 1.3-1.6, the samples showed higher stability and improved properties. The release of 
SA from the organogels was found be combination of Fickian and non-Fickian kinetics. The 
samples showed good antimicrobial study and were found to be biocompatible in nature. 
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1.1. Introduction 
Gels are defined as semi-solid preparations having both solid and liquid components within 
its structure. The solid component forms a networked structure, which results in the 
immobilization of the liquid component. Immobilization of liquid component within the 
networked structure of the solid component has been attributed to the interfacial tension 
amongst the solid and liquid components [1]. The liquid phase may either be polar or apolar 
in nature. If the liquid phase is polar in nature, then the gels may be regarded as hydrogels 
else as organogels [2]. The solid components are regarded as gelator [3]. Some of the 
organogelators (e.g. lecithin, span or tween) accommodate aqueous phase within itself to 
form fiber-like structures, which physically interacts amongst each other, resulting in the 
formation of a networked structure [4]. The organogels developed by this mechanism are 
usually non-crystalline, non-glassy and thermo-reversible in nature [4]. The apolar phase may 
either be mineral oil, organic solvent or vegetable oil. Of late, the research on organogels for 
applications in food, pharmaceutical and cosmetic industry has gained a tremendous 
momentum [4-7]. This may be attributed to the easy production techniques and inherent 
stability of the organogels [8]. Due to their easy spreadability, the organogels are becoming a 
vehicle of choice for cosmetics products and transdermal delivery systems [9]. In the present 
study, tween 80- span 80 mixture based organogels were prepared by fluid-filled structure 
mechanism and were characterized for their probable use as transdermal drug delivery 
vehicle. 
1.2. Objective 
To develop span 80-tween 80 mixture based organogels for probable use in pharmaceutical, 
nutraceutical and cosmetic industries. 
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2. Review of literature 
Based on physical properties, the organogels have been classified into solid matrix and fluid 
filled matrix organogels. The fluid matrix organogels consists of gels made from lecithin or 
Span or Tween. These lecithin or span or tween form a different kind of reverse micelles in 
presence of water and oil. These fluid matrix gels are transparent or opaque and 
thermoreversible in nature. These gels are also called as worm like or polymer like networks 
[10-13].  
2.1. Lecithin organogels 
Lecithin is a zwitter ionic phospholipid with two alkyl tails, which forms spherical or 
ellipsoidal reverse micelles when added to oil [14]. Lecithin is widely used in everyday life 
including human and animal food, medicine, cosmetics and industrial applications [15]. 
These are biocompatible in nature so can be used for longer time periods [16]. They can 
dissolve lipophilic, hydrophilic and ampiphilic moieties in them [17]. These are thermo 
reversible in nature. Up to 40
° 
C they act as gels and above that temperature changes into 
solution state [18]. These organogels exhibit Newtonian fluid behaviour before gelling and 
exhibit maxwell’s rheological behaviour after addition of polar phase [19]. 
 
           
Fig 1: Diagram showing formation of lecithin organogels 
Generally these lecithin organogels are the jelly-like phases, consist of a 3- dimensional 
network of entangled reverse cylindrical (polymer-like) micelles, which immobilizes the 
continuous or macroscopic external organic phase, thus turning a liquid into a gel [20]. 
Lecithin, when dissolves in non polar media alone, self-assembles in to reverse spherical 
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micelles at a concentration of ∼0.01 mM [21]. Further, with the addition of water, this 
spherical reverse micellar state of lipid aggregates turns to form elongated tubular micelles 
(figure 1). Previous studies of reverse worm-like micelles indicated that two conditions are 
needed for substances to induce the growth of reverse worm-like micelles: The substance 
must have at least two functional groups that hydrogen-bond with the phosphate group of 
lecithin and must be slightly hydrophobic to penetrate into the reverse micellar layer [22]. 
Lecithin gels have been reported in a large number of solvents including linear, branched and 
cyclic alkanes, ethers and esters, fatty acids and amines. The amount of water added in order 
to achieve maximum viscosity of gels varies depending on solvent. Kaname and his co-
workers developed organogels by using lecithin, sucrose fatty acid (SFE) ester and dodecane 
oil. In a mixed system of SFE and lecithin, the SFE binds to the phosphate group of 
neighbouring lecithin moieties, reducing the interface curvature of the molecular assembly 
and inducing the formation of reverse worm-like micelles. These reverse worm-like micellar 
regions could be enlarged by increasing lecithin concentration and the hydrophobicity of 
SFE. Ruggero Angelico and his co workers produced organogels by using 
lecithin/water/isopropylpalmitate [23]. The size and the shape of the micelles depend on the 
surfactant chain length, solvent structure, and the type of cosurfactant used and also on the 
concentration of the components. The formation of hydrogen bonding in lecithin organogels 
was studied by using different hydrocarbons like glycerol, formamide and ethylene glycol 
[19]. The ternary mixtures of lecithin, water, and hydrocarbon oil such as cyclohexane exhibit 
a rich phase behaviour, ranging from spherical micellar solutions (droplet-like aggregates), to 
giant worm-like tubular micelles, to a viscoelastic 3-D network of entangled worm-like 
micelles known as organogels [20, 24]. Electro rheological effects(ER) i. e increase in 
viscosity and dynamic shear moduli in lecithin by applying electrical field was studied by 
using oscillating rheology, polarizing microscopy, and electric birefringence [25]. The 
viscoelastic properties of lecithin organogels which included α- and β-anomers of 
alkylglucosides as well as their derivatives containing an alkyl chain of various length was 
also studied [26]. Poorly purified substances did not possess gel forming properties. When 
synthetic lecithins containing residues of saturated fatty acids used for the preparation of gels, 
the organogel formation is  not observed [24]. The researchers have found that lecithin has 
capacity to form organogels in more than 50 items. This includes linear, branched and cyclic 
alkanes, ethers, esters, fatty acids and amines. The exceptions are represented by aromatic 
and chlorinated solvents. In their case the thickening effect is not observed with the addition 
of water because of its inclusion into micelles through a distinctive mechanism [21]. The 
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gelation of edible oil by a mixture of lecithin and sorbitan tri-stearate (STS) was studied. The 
two components individually in oil did not give structurant concentrations between 6% and 
20% w/w. A synergetic effect was observed with their mixture at specific ratios of lecithin: 
STS between 40:60 and 60:40 when firm gels were obtained. The interaction of the two 
structurants was studied by varying concentration and ratio of lecithin: STS and evaluated 
through microscopy, texture analysis, X-ray diffraction (XRD), rheology and nuclear 
magnetic resonance (NMR) [27]. The effect of 1-butanol on the ternary structure of lecithin, 
water and triplamitate was observed. It was found that the lecithin organogels mixed with 1-
butanol showed isotropic liquid phase with no cryatality [28]. The effect of added poly 
(ethylene glycol) monolaurate (PEGML) on the formation and properties of lecithin 
organogels composed of polymer-like micelles was studied by the methods of dynamic 
rheology and the Fourier transform IR spectroscopy. It was established that the addition of 
even small amounts of PEGML causes a significant decrease in viscosity, whereas the elastic 
properties of organogels remained almost unchanged. The desired viscoelastic property can 
be managed by modifying the various formulation components (i.e., selecting the type of 
organic solvent, concentration of gelator or cosurfactant, or the type or amount of polar 
agent), which significantly influence the structural stability and rheological behaviour of 
organogels. The increase in the gelator concentration leads to an increase in the viscosity and 
in turn the gel strength of a soy lecithin-IPP organogel matrix. The Spectral studies revealed 
that the PEGML molecules affect intermolecular hydrogen bonding during their 
incorporation into micelles. This leads to a decrease in the number of hydrogen bonds or their 
weakening and, as a result, to the disintegration of polymer-like lecithin micelles into shorter 
micellar aggregates [20]. The phase behaviour of a ternary system of lecithin/organic 
solvent/polar solvent is mainly governed by the concentration of polar solvent and lecithin. 
This is defined as nw (i.e. molar ratio of polar solvent to lecithin). The phase behaviour of 
lecithin in n-decane employing water as the polar solvent has been discussed. At first, with 
the addition of water, the thickening effect is observed at a certain specific molar ratio of 
water to lecithin. After this threshold concentration, further addition of water leads to a sharp 
increase in the viscosity and the formation of organogel. The organogel state is maintained up 
to a particular molar ratio of water to lecithin, designated as ncr. At the state where nw is equal 
to ncr, the maximum viscosity of organogel is achieved. On continuing the water addition 
above the ncr (i.e., at nw >ncr) the 3-dimensional network collapses and separation of the 
homogenous organogel takes place in a 2-phase system consisting of low viscous liquid and a 
compact organogel or jelly-like phase [29]. The phase behaviour of organogels varies on 
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changing temperature conditions. The phase transition temperature (PTT) of a gel helps in 
optimizing the composition of gel. In one such study, concentration of gelator in a given LO 
(lecithion organogels) formulation was optimized by monitoring the PTTs of the 
organogel[30]. For the determination of PTTs, hot stage microscopy (HSM) and high 
sensitivity differential scanning calorimetry (HSDSC) have been reported to be useful. 
However, the inverse flow method, a simple technique based on visual observations has also 
been employed. 
Table 1: ncr values with different organic solvents employed in lecithin organogel 
systems composed of soyabean lecithin/organic solvent/water in 80:16:4 weight ratio 
[31] 
Solvent ncr 
1,7-octadiene 7 
Butyl laurate 7 
Cyclododecane 12 
Cyclooctane 7 
Dibutyl ether 6 
Ethyl myristate 5 
Isooctane 2 
Isopropyl myristate 3 
Isopropyl palmitate 3 
n-hexadecane 1 
n-hexane 3 
n-octane 2 
Trans-decalin 5 
Tributylamine 2 
Triisobutylamine 3 
 
Nurettin Sahiner and his co workers produced lecithin organogels which contain acryl amide 
hydrogels in it. These hydrogel incorporated organogels are biocompatible and used for drug 
delivery applications. Angela Attar Nasseri and his co workers developed lecithin organogels 
by using isopropyl meristate for topical delivery of ketorolac. For any vehicle to be used for 
topical drug delivery applications, it is essential to study its rheological behaviour. The latter 
is important for its efficacy in delivering the molecules onto or across the skin site. The 
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critical parameters such as spreadability, adhesiveness (property related to bioadhesion on 
skin site) and gel consistency need to be modified in a favourable manner. There are two 
classes of lecithin organogels called as pluronic lecithin organogels (PLOs) and premium 
lecithin organogels (PrLO). The term pluronic refers to a series of non-ionic, closely related 
block copolymers of ethylene oxide and propylene oxide. These PLOs are made up of 
isopropyl palmitate, lecithin, water and pluronic F127. Generally these PLOs are opaque and 
yellowish in colour. Typically 22% (v/v) of oil phase is present in the PLOs [11]. The drugs 
methimazole and diclofenacare already incorporated into PLOs and used for topical route of 
drug delivery [32]. These PLOs are not thoroughly characterized and little is known about its 
physiochemical properties such as structure, rheology, stability and effect of drug 
incorporation etc. The drug Sumatriptan succinate was also entrapped successfully in 
pluronic lecithin organogels to treat nerve disorders. In this study formulations were 
developed with and without co surfactant pluronic F 127. The prepared organogels were 
evaluated for its appearance, organoleptic characteristics, and feel upon application, 
homogeneity, occlusivenes, washability, pH, viscosity, spreadability, gel transition 
temperature of formulations. The formulations were also evaluated for drug content, in vitro 
drug diffusion properties and skin irritation testing. The formulation containing pluronic 
showed greater spreadability and higher drug diffusion rate as compared to pluronic free 
organogel. Pluronic not only enhances the stability of organogel by increasing the viscosity 
but also increases the release of drug [33]. The premium lecithin organogels (PrLOs) are 
second type of lecithin organogels. Generally these are more temperature resistant than other 
gels. There was no skin irritation because these gels do not contain any pluronic derivatives. 
The research done on these PrLOs revealed that by using these gels bioavailability of drugs 
for the tissues has been increased. These gels are marketed generally in ready to use forms 
called as PrLO premixed gels. The bio active agents like diclofenac, ibuprofen, ketoprofen 
and progesterone are successfully entrapped in these gels and also applied intra dermally 
[34]. 
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2.1.2. Mechanism of action of LOs 
The barrier to transdermal delivery is the stratum corneum. The PLO disrupt the lipid layers 
of the stratum corneum without damaging them, as do harsher agents like dimethyl sulfoxide 
(DMSO), which dissolves the lipid layers. The PLO allow the medication to pass through the 
stratum corneum into the systemic circulation via the dermal-epidermal blood flow so that it 
is more likely to be absorbed. 
 
2.1.3. Applications of lecithin organogels for topical drug delivery 
The presence of organic and aqueous phase by means of a structurally well-defined micellar 
network of phospholipids, a large interfacial area, and the ability to entrap solutes within the 
gel matrix, along with long-term stability, makes them useful for a variety of applications. 
The topical applications of various drugs containing LO systems have been demonstrated to 
significantly enhance the skin permeation and absorption of both lipophilic and hydrophilic 
substances. The permeation enhancing effect of the lecithin gel was attributed to the 
vectoring properties of reverse micelles. It was suggested that the micellar entities being 
small in size and with hydrocarbon sheath might had been received by the skin barrier as 
hydrophobic entities, which were allowed for closer interaction with skin barrier leading to 
enhanced permeation of the drug molecules. Therapeutic compounds of different chemical 
and physicochemical background such as muscle relaxants, steroids, hormones, analgesics, 
antiemetics, cardiovascular agents, antithyroid drugs, and some macromolecules have been 
incorporated in the LOs with some very encouraging results. The enhanced skin penetration 
and site-specific delivery of bioactives into the deeper layers of skin has been achieved by 
employing organogels as topical vehicles. An organogel-based (LO or PLO) formulation 
containing extract of saw palmetto (having antiandrogen agent as a principal constituent) 
along with acylcarnitine and coenzyme Q has been reported as an effective formulation for 
the topical treatment of androgenic alopecia. The LOs have  been found to be an excellent 
matrix for the delivery of a macromolecule with a molecular weight of 33,000 daltons. The 
PLO gel containing anti-inflammatory macromolecule bromelain (15%) along with capsaicin 
(0.025%) has been found to be an effective anti-inflammatory composition. Direct 
application of this PLO gel at the site of inflammation has been found to be useful for treating 
a variety of inflammatory indications. Willimann and co-workers investigated these systems 
for their role in trans-skin permeation of drugs by employing different organic solvents. The 
solubility of various drugs such as nifedipine, clonidine, scopolamine, and broxaterol was 
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noted to be increased in lecithin-IPP solution compared with the drug solubility in IPP alone, 
suggesting the solubility enhancing properties of the organogels. The IPP-based lecithin gel 
exhibited higher transdermal transport efficiency than that of cyclooctane lecithin gel. This 
difference in trans-skin delivery rate was due to the penetration enhancing property of the 
IPP. Bhatnagar and Vyas have investigated the trans-skin permeability of propranolol 
hydrochloride, a poorly permeable and water-soluble drug incorporated in LOs, across human 
cadaver skin. The LOs are alsoused for the topical administration of systemic hormones. The 
transdermal delivery of progesterone, incorporated in LOs, has been studied with an aim to 
minimize the bioavailability fluctuations associated with its preoral administration. Also, a 
transdermal formulation of testosterone has been successfully prepared by incorporating the 
therapeutically effective amounts of micronized testosterone in a PLO gel [34]. Angela attar 
nasseri and his co workers prepared lecithin organogels for topical application of Ketorolac 
Tromethamine (KT). They have prepared organogel by using lecithin and isopropyl myristate 
(IPM). The release profile of ketorolac was studied by using intact guinea pig skin and 
various artificial membranes. It was observed that as the lecithin concentration increased 
from 40 to 50 and then 60% w/w in formulations, a significant decrease in KT release was 
obtained. A remarkable increase in the drug release was also observed in formulations 
containing 6.5% w/w of KT compared to those containing 1% w/w of the drug. The 
optimized formulation of the organogel composed of 40% lecithin and 60% IPM (containing 
0.6% w/w of water and 6.5% w/w of KT) showed the highest drug release rate. Increasing the 
water content of the organogels also resulted in an increase in KT release. The results have 
shown that KT could be incorporated at high concentrations into lecithin organogels and 
these systems could be considered as desirable drug delivery vehicles for water soluble drugs 
and are capable of providing an appropriate drug release rate. Sheikh and his co workers 
developed lecithin based organogels for topical delivery of aceclofenac drug. In this study 
they have prepared gel from lecithin, glacial acetic acid and water. These aceclofenal LOs 
have been characterized invivo and invitro environments. Findings of this study suggest that 
lecithin based organogels is able to provide desired anti-inflammatory action. In vitro skin 
permeation study demonstrated that ethyl oleate based organogel was effective in providing 
faster drug release. In vivo study confirmed the findings of in vitro study. The use of 
antibiotics in PLO has not been well documented clinically in humans. The Scientists also 
found that lidocaine, guaifenesin, and amitriptyline may break down PLO and make these 
gels thin [18, 35]. Most of the preparations that contain PLO should be stored at room 
temperature. If the active drug is not stable at room temperature, the gel must be refrigerated 
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and that can present problems because PLO may separate under refrigeration. Those 
preparations can be remixed by means of shear force to ensure micelle formation.The table 2 
provides and 3 provide  information about the drugs that are being incorporated by using 
lecithin organogels.  
Table 2: Applications of lecithin organogels 
S.NO COMPONENTS MODEL DRUG APPLICATION 
1 Lecithin, water and isopropyl palmitate Scopolomins 
broxaterol 
Treatment of asthma 
[18, 35] 
2 Lecithin, sodium caprylate and sorbitan 
monooleate 
Lidocaine Treatment of neural 
disorders [36] 
3 Lecithin, water and sorbitan monooleate Digoxin 
 
cyclobenzaprin 
Treatment of bruxism 
[37]  
For muscle relaxation 
4. Lecithin, water and isopropyl meristate Methyl Nicotinate Induction of erythema 
[38] 
5 Lecithin, water, isopropyl meristate 
Pluronic F 127 
Sumatriptan succinate Treatment of nerve 
disorders [39] 
 
 
Table 3: Commercially available pluronic lecithin organogels (Data obtained from 
Stafford pharmacy and home health care) 
S.No Therapeutic Category Therapeutic Agents 
1 Antiemetics Dexamethasone, dimenhydrate, scopolamine 
2 Muscle relaxants Cyclobenzaprine, baclofen, buspirone 
3 Neuropathy drugs Clonidine, capsaicin, amitryptiline, gabapentin, 
phenytoin, 
4 NSAIDs (non steroidal anti-
inflammatory drugs) 
Diclofenac, ibuprofen, ketoprofen, indomethacin, 
5 Systemic analgesics Acetaminophen, hydromorphone, morphine sulfate 
6 Systemic hormones Progesterone, testosterone 
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2.1.4. Applications of lecithin organogels for ophthalmic drug delivery 
There are many types of dosage forms like eye drops, suspensions and ointments are 
available for treatment of ophthalmic problems. But in case of eye drops there is a 
disadvantage of washing out of eye drops due to eye tears. Therefore only some part of drug 
reaches target tissue. In suspensions usage one disadvantage is that rate of drug release 
depends on the dissolution of drug in the suspension mixture. So lecithin organogels can be 
used for ophthalmic drug delivery because they release the drug at steady rate and highly 
viscous so hard to wash out. We can incorporate variety of drugs(i. e lipophilic, hydrophilic 
an ampiphilic). Three lecithin organogel systems have been developed for ophthalmic drug 
delivery by using paraffin, isopropyl palmitate and cyclooctane. In this paraffin based lecithin 
organogels found to be safest compared to other two organogels [40]. 
 
2.2. Span and Tween based organogels 
The surfactants are ampiphilic in nature by having both the hydrophilic and hydrophobic 
groups. The surfactants have the ability to transform into microstructures of spherical, rod or 
inverted micelles. The spherical micelles formed by surfactant has low viscosity while rod 
shaped micelles has higher viscosity properties. The rheological properties of surfactant 
depend on microstructure. The surfactants that are widely used for drug delivery are sorbitan 
mono state (Span 60) and sorbitan mono plamitate (Span 40). Multi component organogels 
have been developed by using non ionic surfactants as gelators like sorbitan monosterate. 
Some of the studies were done on these organogels to know the drug delivery efficiency. 
Murdan and his co workers have prepared surfactant based organogels by using sorbitan 
monosterate/polysorbate 20. First they have prepared hot (60°C) suspension of noisome (v/w) 
and this suspension was added to solution of sorbitan monostearate (v/v) by this water in oil 
emulsion was produced. Upon cooling this emulsion was turned into semi solid gel. It has 
also been established that the water-to-surfactant molar ratio (w= [H2O]/[Surfactant]) is an 
important factor in controlling the formation of rod shaped reversed micelles. The formation 
of these reversed micelles can also enhanced by using co surfactants like polar solute with 
alcohol or amine. The structural evolution such as entanglement, micellar growth and 
branching can be predicted on the basis of the rheological behaviour and small-angle 
scattering techniques using X rays or neutrons which provide direct evidences of micellar 
growth. SANS data suggest that Na
+
, Mg
2+
, Ca
2+
 all form spherical droplets whilst Ni
2+
, Co
2+ 
and Zn
2+
 induce rod shaped aggregates [41]. The light microscopy results of these organogels 
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proved that the gel microstructure contains tubular gelator network in which the noisome 
suspension being entrapped tightly. Hence these scientists thought to entrap vaccines into 
these organogels. They have entrapped bovine serum albumin (BSA) and haemagglutinin 
(HA) as antigens (depots) into these gels. The immunogenicity studies of these gels have 
been conducted in vivo by applying these gels at intra muscular regions. The result shown 
there was a rise of antibody production against these two antigens. But the short lived nature 
of depot was observed, this might be due to the interactions of gel components with that of 
depot [42]. Another surfactant used for preparation of organogel was sodiumbis (2-
ethylhexyl) sulfosuccinate (AOT). In this study AOT based gel was prepared by entrapping 
benzenediols (resorcinol derivatives). The NMR and FTIR studies done on these gels proved 
that hydrogen bonding between the surfactant molecules lead to the formation of mesh like 
structure and benzenediol forms binding with surfactant by using two carbonyl groups of 
surfactant. It was also proved that organogels prepared by using benzenediols were highly 
stable when compared to the gels prepared using phenol. This was because phenol uses only 
one carbonyl group of surfactant to from gel where as benzenediol uses both the carbonyl 
groups of surfactant to form stable gel [43]. The hydrophile-lipophile balance (HLB) for 
emulsification also plays important role in formation of either oil in water or water in oil 
emulsions. Generally HLB value of 6 results in formation of water in oil emulsion where as 
HLB value of 14 results in formation of oil in water emulsion. The applied shear conditions 
also have effect on formation of semi solid organogels. Under high shear, low internal phase 
emulsions formed using surfactant mixtures (span 80/tween 80). But at lower shear, high 
internal phase emulsions resulted.  From these results, it appears that the emulsification 
method (applied shear and oil/water ratio) used can be of greater importance in determing the 
final emulsion type than the HLB values of the surfactants themselves [44]. The HLB value 
of the surfactant indicates the solubility of the surfactant. If the surfactant has lower HLB 
value then surfactant is more lipophilic or oil soluble or if the surfactant has higher HLB 
value then surfactant is more hydrophilic or water soluble. For the surfactant system several 
studies recommend that use a blend of at least two surfactants. This is due to mixtures of a 
low HLB and a high HLB surfactant give better coverage at the interface and a  blend of two 
surfactants is typical. 
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 Table 4: HLB values of Span 80/Tween 80 blends 
HLB value Span 80 (%) Tween 80 (%) 
4 100 --- 
6 83 17 
8 65 35 
10 46 54 
12 28 72 
14 9 91 
15 --- 100 
 
Table 5: HLB values of some of surfactants 
Name of the surfactant  HLB value 
Sorbitan trioleate (Span 85) 1.8 
Sorbitan tristearate (Span 65) 2.1 
Sorbitan sesquioleate (Arlacel 83) 3.7 
Glyceryl monostearate, 3.8 
Sorbitan monooleate (Span 80) 4.3 
Sorbitan monostearate (Span 60) 4.7 
Sorbitan monopalmitate (Span 40) 6.7 
Sorbitan monolaurate (Span 20) 8.6 
Polyoxyethylene sorbitan tristearate (Tween 
65) 
10.5 
Polyoxyethylene sorbitan trioleate (Tween 
85) 
11.0 
Polyethylene glycol 400 monostearate 11.6 
Polysorbate 60 (Tween 60) 14.9 
Polyoxyethylene monostearate (Myrj 49) 15.0 
Polysorbate 80 (Tween 80) 15.0 
Polysorbate 40 (Tween 40) 15.6 
Polysorbate 20 (Tween 20) 16.7 
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2.2.2. Applications of Span-tween based organogels in drug delivery 
Non-ionic surfactants can be useful alternatives to naturally occurring surfactants, and 
polyoxyethylene Mono sorbitan n-acyl esters (Tweens), for example, have been reported to 
have minimal toxicity. Although there are some exceptions, the use of poly-oxyethylene 
sorbitan monooleate (Tween 80) appears acceptable for only oral or parenteral 
applications[9]. One of research done by murdan and his co workers revealed that the 
molecules present in non ionic surfactant (sorbitan mono stearate) based organogels has short 
half life period. In vitro results of this study gave the reason behind this unusual 
phenomenon. Actually when a surfactant based organogel is applied intra muscularly the 
outer surface of gel comes into contact with interstitial fluid present at that site. This fluid 
slowly causes breakdown sorbitan mono stearate tubules and then degradation of gel into 
smaller fragments. The surfactant tubules act as conduit for water penetration into gel. This 
leads to gradual erosion of gel into oil droplets from the gel mass. Actually fluid penetration 
and emulsification at gel surface are responsible for gel breakdown at injection site [45].  
Table 6: Surfactant based organogels for cutaneous drug delivery (in vitro) 
S.No Organogel components Model Drug Used membrane 
1 Tween 80, Span 80, IPM and water 8-Methoxsalen Pig skin [46] 
2 Tween 80, Span 20, IPM and water Diphenhydramine 
hydrochloride 
Human skin [6] 
3 Tween 80, Span 80, IPM and water Methotrexate Pig skin [47] 
4 Tween 21/81/85,Bis 2-silphosuccinate, 
IPM and water 
Sodium salicylate Pig skin [48] 
 
Table 7: Surfactant based organogels for cutaneous drug delivery (in vivo) 
S.No Organogel components Model Drug Used animal 
1 Tween 85, Targat, mono oleate, IPP 
and Glycerol 
Bupranolol Rabbit [49] 
 Tween 85, Prolaxamer, IPP and 
Glycerol 
Bupranolol Rabbit [49] 
2 Tween 85, IPP and Glycerol Carazolol Rabbit [49] 
3 Tween 85, IPP and water Hydro chloride 
trimolol 
Rabbit [6] 
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The surfactants behave as permeation enhancers. The effects that are caused due to these 
organogels are investigated on shaved mouse as well as on human skin. In both cases, no 
significant increase of blood flow and in epidermal irritation was observed. Over all the 
organogels are regarded as safe [50]. 
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CHAPTER-03 
MATERIALS AND METHODS 
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3. Materials and Methods 
3.1 Materials 
Span 80 (sorbitan monooleate) was procured from Loba chemie, Mumbai, India. Tween 80 
(polyoxyethylene sorbitan monooleate), rhodamine B and salicylic acid (SA, model drug) 
were procured from Himedia, Mumbai, India. Edible sunflower oil (SO) was purchased from 
the local market. Dialysis membrane (MW cut-off - 60 kDa) was purchased from Himedia, 
Mumbai, India. Double distilled water was used throughout the study. 
 
3.2 Methods 
A. Preparation of organogels 
Span 80 and tween 80 were mixed thoroughly in the proportion of 1:2 ratio (w/w) to obtain 
the surfactant mixture (SM), which was used as gelator. Specified amount of the SM was 
added to the SO, kept on stirring on a magnetic stirrer. The above mixture (gelator solution, 
GS) was stirred for 20 min. Subsequently, water was added drop-by-drop to the GS using a 
burette until there was a formation of organogel or the total fraction of water has reached 
80% of the volume of the GS-water mixture. Depending on the composition of the GS-water 
mixture, the system either formed gelled structures or remained as liquid mixtures. A ternary 
plot depicting the proportions of SM, water and SO was prepared to figure out the 
compositions, which formed organogels. 
Samples for morphological studies were prepared in a similar manner using 0.01 % (w/v) 
aqueous rhodamine B solution as the polar phase. SA-loaded samples were prepared by 
dispersing SA into the SO, which was subsequently used for the development of organogels. 
The final concentration of SA in organogels was maintained at 1 % (w/w). 
 
 
B. Characterization of organogels was carried out by using following methods 
Microscopic study 
To understand the mechanism of organogels formation, water was slowly added to the GS 
(95.83 %, w/w) until the formation of the organogel. The samples were observed under 
compound microscope (H600 AFL50, Hund, Germany) as the proportion of water was 
varied. The microstructures were analyzed using ImageJ software. 
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Gel-sol transition study 
Gel-sol transition temperature (Tgs) was found out by incubating the organogels in a water-
bath, whose temperature was varied from 30-70 ºC. The temperature, at which the gels started 
to flow, when the glass vials were inverted, was noted as the gel-sol transition [51]. 
Stability analysis of the organogels  
The stability of the pharmaceutical products may be carried out either by thermocycling 
process or by incubating the samples at a particular environment for a longer period of time 
[52]. 
Alternate heating and cooling of emulsions for a particular period can help estimating 
stability of the emulsions [53]. Since the developed organogels contain dispersed aqueous 
phase in an oil continuous phase, they may be considered as water-in-oil emulsion gels. The 
organogels were alternatively incubated for 15 min at temperatures of 70
o
C and -20
o
C. The 
samples were regarded as stable samples, if the organogels withstood at least 5 cycles of 
thermocycling. 
ICH guidelines of stability of pharmaceutical products indicates the storage of the products at 
30°C ± 2ºC for 12 months (long-term stability) and 6 months (intermediate stability) [3]. The 
organogel samples were incubated at 30°C ± 2°C RH for 9 months to figure out any signs of 
destabilization. 
X-ray diffraction study 
Three stable samples and their corresponding SA-loaded samples were analyzed by XRD 
(XRD-PW 1700, Philips, Rockville, USA) using Cu-Kα radiation generated at 30kV and 20 
mA. The samples were analyzed in the range of diffraction angle of 10º to 50º-2θ at a rate of 
2° 2θ per min.     
 
FTIR analysis 
A representative blank organogel and its corresponding SA-loaded organogel were subjected 
to FTIR spectroscopy in the range of 450-4000 cm
-1
. An ATR-FTIR spectroscope (AlphaE 
ATR-FTIR, Bruker, USA) was used for the study.  
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Thermal analysis 
Thermal analysis of organogels was done by simultaneous thermogravimetric analysis (TGA) 
and differential thermal analysis (DTA) using H-Res/modulated TGA-DTA 2950 (TA 
instruments, USA) in the temperature range of 25
o
C to 300
o
C at a heating rate of 6
o
C/min.    
pH measurement 
The pH of the organogels was measured using a digital pH meter (Model 132E, EI products, 
India). The pH was measured to figure out whether the pH of the organogels lie within the 
limits of skin pH [54]. 
Impedance measurement 
DC impedance of the organogels were measured using an in-house developed DC impedance 
measuring unit. The impedance was measured both during the thermocycling stability test 
and on a time scale basis for the samples incubated at 30°C ± 2°C. 
Invitro drug release studies  
A two-compartment cell was used for the drug release study. The compartments were 
separated by a dialysis membrane (MW cut-off - 60 kDa, Himedia, Mumbai). The donor 
compartment contained 5 g of SA loaded organogels while the receptor compartment 
contained 50 ml of water. The donor compartment was lowered to ensure that the dialysis 
membrane was in contact with the receptor fluid, kept on stirring at 100 rpm. For the first 1h, 
the 50 ml water was completely replaced with fresh 50 ml water at an interval of 15 min. 
Subsequently, the replacement of the water was done at an interval of 30 min until 8
 
h. A 
portion of the replaced water was kept for further analysis under UV-vis spectrophotometer 
(Shimadzu UV 1601 r, Equipment for technology and science, Sanjose) at a wavelength of 
294 nm. All the experiments were carried out in duplicates. 
Antimicrobial test  
Gram positive bacterium Bacillus subtilis (MTCC 121) was used for antimicrobial study. 
Nutrient agar solid (peptone-0.5%, beef extract-0.3%, agar-1.5% and Nacl-0.5% in 100ml of 
distilled water) was used as a culture media for the study. 1 ml of cell suspension (containing 
10
-6
 to10
-7 
cfu/ml) in water was spread over the surface of the nutrient solid agar media. 
Wells of 9 mm diameter were made into the agar plates using a borer so as to accommodate 
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0.5 g of drug loaded organogel. The petri-dishes were incubated at 37ºC for 24 h to allow the 
growth of the bacteria. The zone of inhibition was measured by using a ruler at the end of 24 
h.  
Hemocompatibility test 
The organogel was enclosed in dialysis tubing and kept in 50 ml normal saline at 37 
o
C for 30 
min so as to allow the leaching of components from the organogels, if any. 0.5 ml of this 
solution is then diluted with 0.5 ml of diluted goat blood (prepared by diluting 8 ml of goat 
blood with 10 ml of normal saline) followed by the addition of 9 ml of normal saline and 
incubation at 37 
o
C for 1 h. Subsequently, the above suspension was centrifuged at 3000 rpm 
for 10 min. Similarly, positive and negative controls were also prepared. The normal saline 
containing the leached components in the test sample are replaced with 0.1 N hydrochloric 
acid and normal saline for positive and negative controls, respectively. The supernatant was 
siphoned off and analyzed at 545 nm using a UV-visible spectrophotometer. The % 
haemolysis was calculated from the following equation: 
                        
% 100
Test Negative
Positive Negative
OD OD
Hemolysis
OD OD

 

 
As per accepted norm, if the % hemolysis ≤ 5 and ≤ 10 for a test material then the sample is 
regarded as highly hemocompatible and hemocompatible, respectively. 
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CHAPTER-04 
RESULTS AND DISCUSSIONS 
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4. Results and Discussion 
4.1. Preparation of organogels 
The organogels were prepared by dissolving the SM in SO (GS) followed by the addition of 
water. With the initial addition of water, the mixture turns into white turbid solution. As 
further amount of water was added, the samples either formed a gelled structure or remained 
as turbid solution. The samples were regarded as organogels, if the GS-water mixture did not 
flow when the culture bottles were inverted (Figure 2). The samples which formed gelled 
structures, released heat indicating an exothermic reaction as the gels were developed. A 
change of 5.3
o
C was observed during the process. This indicates that the samples attain a low 
energy state as they undergo transition into gelled structures and attain a thermodynamically 
stable state. Depending on the composition, colour of the gels varied from white to pale 
yellow. All the gels were opaque in nature. They were having slight odour and oily to touch. 
 
                                          
Figure 2: Organogel samples of different composition 
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Figure 3: Ternary phase diagram of organogels  
By varying the SM, oil and water composition, 780 sample points (approx.) were taken to 
figure out the compositions which lead to the formation of gels. Based on the 
experimentation, the compositions of gels were plotted in a triplot (figure 3). The gel fraction 
was found to be 16.6% (approx.). 15 compositions, throughout the gelled area, were selected 
randomly from the gelled compositions for in-depth analysis. Table 1 enlists the composition 
of the selected gels for further analysis. 
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Table 8: Composition of the gels used for further analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample Surfactant 
(Fraction) 
Water 
( Fraction ) 
Oil 
( Fraction ) 
A 0.30 0.25 0.45 
B 0.35 0.15 0.50 
C 0.35 0.20 0.45 
D 0.35 0.25 0.40 
E 0.40 0.25 0.35 
F 0.425 0.40 0.175 
G 0.525 0.15 0.325 
H 0.625 0.20 0.175 
I 0.575 0.40 0.025 
J 0.50 0.35 0.15 
K 0.525 0.4 0.075 
L 0.550 0.35 0.1 
M 0.525 0.30 0.175 
N 0.70 0.25 0.05 
O 0.525 0.35 0.125 
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4.2. Microscopic study  
The microstructure of the GS was studied under microscope as different proportions of water 
were added to the GS (figure 4). The micrographs suggested that GS showed some irregular 
structures. As water was added to the GS, there was formation of globular structures. There 
was an increase in the number of the globular structures as the proportion of water was 
increased in GS. The morphological analysis of the globular structure indicated that there was 
a decrease in the size of the globular as the proportion of water was increased in the GS 
(figure 5).  From the microscopic results it can be predicted that on addition of water in GS, 
there is a formation of globular reverse micellar structures having internal aqueous phase. 
These reverse micellar structures physically interacts with each other to form a three 
dimensional networked structure thereby resulting in the immobilization of the organic phase.  
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Figure 4: Microscopic study of GS with various proportions of water. a) 0.0 ml, (b) 2.0 
ml, (c) 2.5ml, (d) 3.0 ml, (e) 3.5 ml, and (f) 4ml of water.  
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(b) 
Figure 5: Frequency distribution of globular particles as the water proportions were 
varied. (a) Number of particles (b) Cumulative % of particles 
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4.3. Gel-sol transition analysis 
The organogels were subjected to increasing temperature starting from 25ºC. An increment of 
5ºC was made after 5 min of incubation at the previous temperature. The samples were 
considered to have undergone gel-sol transition, when they started to flow (figure 5) [53]. 
The gel-to-sol transition temperature of the organogels varied from 40
o
C to 70
o
C, depending 
on the composition of the organogels (Table 9). As the temperature increased, there was a  
corresponding increase in the surface free energy with the subsequent increase in mobility of 
the self-assembled structures formed by the gelators. With further increase in temperature, the 
interactions amongst the self-assembled structures gets reduced which  leads to the disruption 
of  networked structure, thereby causing the gelled system to flow freely [41].   
In general, the gel-sol transition was found to be >60
o
C for the samples having SM: water 
ratio in the range of 1.3 to 1.6 (w/w), with an exception of sample L. Any deviation from this 
leads to the decrease in the Tgs, indicating that the proportions of SM and water plays an 
important role in the formation of a thermodynamically stable gel.  
Table 9: Results of gel-sol transition study 
S. No. Sample  Tgs 
(°C) 
1 A 35 
2 B, G, N 40 
3 M 45 
4 C, F, H, L 50 
5 J, K 60 
6 D, E 65 
7 I, O 70 
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(a)                                                         (b)                                             
Figure 6: Gel-sol analysis. (a) Sample E at 30º C and (b) Sample E at 65 º C. 
4.4. Accelerated thermal stability study of organogels 
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Figure 7: Temperature profile used for accelerated study  
The accelerated stability testing of organogels were carried out as per the temperature profile 
given in the figure 7. The method employs continuous exposure of the samples to a freeze-
thaw cycle at short intervals of time. The freezing temperature should be ≤ -5ºC whereas the 
thawing temperature is dependent on the type of formulation [55]. This method only provides 
a prediction and does not give us an absolute value. This has been attributed to the process of 
destabilization only during freeze-thaw cycles and not under storage conditions [55]. The 
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rupture of the surfactant layer in the presence of ice crystals at lower temperatures and or 
change in the physic-chemical property of the surfactant layer at higher temperatures leads to 
instability of organogels. In general, it is considered that the samples should withstand at least 
5 cycles of freeze-thawing process. Thermocycling studies were done for all the 15 samples. 
From this study it was observed that samples E, I and L were stable even after 5 cycles of 
thermocycling indicating that these samples may be stable for a prolonged period of time 
(Figure 8). The results of the experiment have been tabulated in table 10. 
Table 10: Results of accelerated thermal study 
S.No Sample Stability 
1 G, J, K, N, C Destabilized within 1 cycle 
2 B, F, H, O Stable up to 2 cycles 
3 A, D, M Stable  up to 4 cycles 
4 E, I, L Stable for >5 cycles 
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Figure 8: Samples showing the results of thermocycling 
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In a separate study, samples were kept at 30°C ± 2°C.  Observations of the experiment have 
been tabulated in table 11. The stability of these organogels was manually checked at 
different intervals of time. The study indicates that depending on the composition of the 
organogels, the products may be stored at 30°C ± 2°C/65% RH ± 5% RH for the period 
varying from 6 months to 12 months.  As per the ICH guidelines, the products withstanding 
the 30°C ± 2°C/65% RH ± 5% RH environment for 6 months are regarded as intermediate 
stable products while if they are stable for more than 12 months, they are regarded as long-
term stable products [56]. The samples E, F and M may be regarded as intermediate stable 
products while the samples D, I, J, L and O were stable after 9 months of study and may be 
regarded as long-term stable products if they are found to be stable for 12 months. 
Compositional comparison of these intermediate and long term stable gels concludes that 
they are also having SM and water ratio in the range of 1.3 to 1.6 with the exception of F and 
M.  
Table 11: Results of stability studies on time scale 
S.No Sample Stability 
1 G,H,N Stable for 1 week 
2 A,B,C Stable for 3 weeks 
3 K Stable for 5 months 
4 E,F,M Stable for 7 moths 
5 D,I,J,L,O Stable for 9 months* 
       * stable after 9 months also 
Based on the results of stability studies (Tgs, accelerated thermal stability and stability based 
on time scale), it was cleared that the stability of these organogels is highly dependent on 
their composition. It was confirmed that the organogels having SM and water ratio in the 
range of 1.3 to 1.6 were highly stable when compared to others. The samples E, I and L were 
selected for the further studies as they found to be stable after the for both stability tests.        
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4.5. X-ray diffraction analysis of organogels 
 The selected organogels (E, I and L) and their corresponding gels with SA (ED, ID and LD) 
were analyzed by XRD to understand the effect of drug on the crystallinity of the organogels 
(figure 9). The full widths at half maximum (FWHM) and area under the curve (AUC) values 
for all the samples have been tabulated in Table 12.     
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Figure 9: XRD analysis of the samples. (a) L, LD organogels (b) I, ID organogels  (c) E, 
ED organogels and (d) Salicylic acid 
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Table 12: Values of FWHM and AUC for XRD study 
S.No Sample   FWHM  AUC 
1 E 10.36 1652.11 
2 ED  11.34  1772.10 
3 I  13.74 1871.06 
4 ID  20.64 2377.53 
5 L  17.62  2108.91 
6 LD  21.13  2339.21 
 
Figure 9 shows the X-ray diffractograms of the organogel samples and SA. The presence of a 
single broad peak at 20° 2θ for all the blank organogels and drug loaded organogels indicate 
amorphous dominant nature of the samples with very low crystallinity. The amorphous nature 
of the samples was in the order of E < I < L as evident from the FWHM values of 10.36, 
13.74 and 17.62 for E, I and L samples, respectively. The amorphous nature has been related 
to the fluid matrix systems with no solid-fibrillar networks and absence of regular geometric 
structures. The crystalline fraction may be attributed to the presence of the bilayered inverse 
micellar tubular network formed by the surfactants upon addition of water [57]. SA showed 
three sharp peaks at 10°, 18°  and 30° 2θ indicating its crystalline nature.  But as SA was 
incorporated in the gels no peaks corresponding to SA was found. This can be explained by 
the solubility of SA in the oil fraction of gels [58]. SA increased the amorphous nature, 
evident from the increased FWHM and AUC (table 12), of the gels thereby facilitating the 
easy diffusion of SA from the gel matrices [59].  
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4.7. FT-IR analysis 
 
Figure 10: Graph showing the result of FT-IR analysis 
Fourier transform infrared spectroscopy indicates the presence of molecular interactions 
amongst the components present in a sample. Sample I was used as the representative blank 
organogel and sample ID was used as the drug loaded sample. The spectra of the samples I 
and ID organogels was found to be similar (figure 10). A shallow broad peak was observed in 
the range of 3,700 cm
-1
 to 3,100 cm
-1 
wave numbers in both the cases suggesting the presence 
of stretched hydrogen bonded O-H groups in the samples. This indicates that presence of 
intermolecular hydrogen bonds amongst the water and the surfactants resulting in the 
formation of inverse tubular structures, which upon extension and physical crosslinking 
yields fluid matrix gel [19]. The spectra of sample ID indicated additional peak at 572 cm
-1
 in 
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addition to the peaks at 468 cm
-1
 and 512 cm
-1
 which were also present in sample I organogel. 
This indicates the presence of the aromatic ring of the SA present in the organogel.  
4.8. Thermal analysis 
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Figure 11: TGA-DTA thermograms of I and ID organogels (a) TGA (b) DTA  
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TGA thermograms of samples I and ID organogel have been shown in figure 11a. Organogels 
started losing their weight as the temperature was increased from room temperature to 100°C, 
indicates their gelled structure is being disturbed. About 40 to 45% weight loss occurred up to 
100°C, which might be attributed to the evaporation of water. The percentage weight loss of 
gel is in accordance with the initial weight percentage of water in sample i.e. 40% (w/w) (see 
Table 1). Up to 62°C, steep decrease in weight loss was observed and with a subsequent 
gradual decrease in weight till 100 °C. Constant weight was maintained up to 240°C and then 
weight loss continued till 300°C [60]. DTA thermograms of samples I and ID organogels 
have been shown in figure 11b. The melting temperatures for I and ID organogels were 
observed at 62 ºC and 58 ºC, respectively. This supports the XRD observation that the 
addition of drug into the organogels resulted in the decreased physical interactions amongst 
the reverse-micellar tubules. The lesser the physical interactions, lesser will be the melting 
temperature of the gels. The complete evaporation temperatures of water were observed at 
100ºC and 92ºC.  
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4.9. pH measurement 
The pH of organogels was measured at 30ºC ± 2ºC by using electrode based digital pH meter. 
The pH values for all samples given in Table 13. 
Table 13: pH values of organogels 
Sample  pH±SD 
A 6.69±0.012 
B 7.13±0.016 
C 7.24±0.011 
D 7.10±0.013 
E 7.01±0.016 
F 6.80±0.017 
G 7.27±0.010 
H 7.25±0.011 
I 7.15±0.009 
J 7.15±0.090 
K 7.23±0.010 
L 7.20±0.011 
M 7.37±0.080 
N 7.31±0.090 
O 7.20±0.010 
 
The pH values of organogels varied in the range of 6.69 to 7.37. The pH of the organogels 
were in accordance to the USP guidelines for topical and transdermal formulations. 
According to USP the pH of gels or ointments whichever to be used for topical or 
transdermal applications should lie within the limits of normal skin pH of 4.5-7.4. If not so, 
immunological responses like redness, burning and itching of the skin in the applied area will 
results [54].  
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4.10. Impedance measurement 
Table 14: Impedance values of organogels 
SAMPLE No. IMPEDANCE (IN OHMS) ±SD 
A 0.105±0.021 
B 0.227±0.023 
C 0.128±0.015 
D 0.091±0.009 
E 0.092±0.013 
F 0.062±0.012 
G 0.230±0.017 
H 0.162±0.011 
I 0.075±0.008 
J 0.075±0.006 
K 0.063±0.005 
L 0.076±0.013 
M 0.08±0.007 
N 0.128±0.015 
O 0.078±0.008 
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Figure 12: Graph showing plot between no. of thermo cycles Vs impedance values 
The impedance of the organogels has been tabulated in table 14. The results indicate that 
there was a decrease in the impedance of the organogels as the proportions of water was 
decreased in the organogels.   
The impedance analysis after every cycle of thermocycling indicated an increase in the 
impedance of the organogels. There was less change in impedance in case of stable 
organogels but there was a greater variation in the impedance for the destabilized organogels 
(figure 12). This may be attributed to the exclusion of oil from gel structure which results in 
the increment of the impedance of the organogel samples. 
In a separate study, the impedance of the organogel samples B, E, I, L and O were measured 
on a daily basis for 21 days. The results indicated that the impedance of the samples E, I, L 
and O were relatively constant while the sample B organogel showed a wide variation in the 
impedance over a period of 21 days (figure 13). The variation in the impedance of the sample 
B organogel may be related destabilization. The increase in the impedance up to day 7 may 
be attributed to the leaching of the oil from the gelled structures whereas the subsequent 
decrease may be attributed to the destabilization of the reverse-micellar structures with the 
subsequent release of the aqueous phase. Since samples E, I, L and O were relatively stable 
for a longer duration, no drastic change in the impedance was observed [7]. 
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Figure 13: Graph showing plot between No. of days Vs Impedance values 
4.11. Antimicrobial test 
The sample ID organogel was used for antimicrobial test using B. subtilis as the test 
organism. The pure drug was taken as positive control and organogel without drug was taken 
as negative control. Table 15 shows the results of the test. It was found that SA was able to 
inhibit the proliferation of the microorganism within a given area and did not allow the 
growth of the microorganism even after 24 h. On the other hand, sample I did not show any 
zone of inhibition. This indicates that the organogels may be tried as matrices for controlled 
delivery system, where it may deliver the bioactive agent for a prolonged period of time. 
Table 15: Results of antimicrobial test 
 
 
 
 
 
 
 
Bioactive agent Zone of inhibition(Diameter, cm) 
 B. subtilis Positive control Negative 
control 
Salicylic acid(1%) 1.5±0.2 
  
 
2±0.3 Nil 
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4.12. In vitro drug release study 
The release profiles of the drug from the organogels have been shown in figure 13. The rate 
of release of SA was higher in sample ID organogel followed by samples LD and ED 
organogels (figure 14). The low CPDR value indicates the controlled release behaviour of the 
formulation and is reckoned to be the feature of amphiphilogels. In PC/Span 60/SO gels only 
18% piroxicam drug was released even after 40h of in vitro drug release study [61]. The 
results indicate that as the amorphous nature of the organogels increased, there was a 
subsequent increase in the rate of release of the drug. As a matter of fact, the increase in 
crystallinity increases the crystallite domains, which results in the decrease in the diffusion of 
the drugs from the organogels and may explain the release profiles obtained for samples ED, 
ID and LD [62]. 
Table 16 shows the rate constants determined for different kinetic models of drug release. 
The best-fit model for release kinetics indicated that the release of the drug from the 
organogels followed Weibull Model kinetics (figure 15). This suggests that the organogels 
may be used as controlled delivery systems [63]. Korsmeyer-Peppas model was used to 
figure out the Fickian constant ‘n’. The n value was found to be in between 0.5 and 0.7, 
suggesting that the release mechanism was a combination of both Fickian and non-Fickian 
kinetics [64]. 
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Figure 14: CPDR values for different compositions of the organogel samples as a 
function of time 
44 | P a g e  
 
 
Table 16: Kinetics of drug release  
 Zero order First order Higuchi Weibu
ll 
Korsmeyer-
Peppas  
Best-fit 
model 
r
2 
k r
2
 k r
2
 k r
2
 r
2
 n                                  
ED 0.979 8.726 0.830 0.001 0.971 0.379 0.996 0.99
6 
0.662 Weibull; 
Fickian and 
Non fickian  
ID 0.981 9.440 0.837 0.001 0.965 0.416 0.996 0.99
6 
0.676 Weibull; 
Fickian and 
Non fickian  
LD 0.980 9.335 0.820 0.001 0.968 0.420 0.995 0.99
5 
0.687 Weibull; 
Fickian and 
Non fickian  
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Where, D is the drug dissolved in receptor medium and T is the time  
Figure 15: Weibull-model kinetics for the different organogels samples ED, ID and LD 
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4.13. Hemocompatability test 
The hemocompatability test was performed for samples E, I and L. The results of study have 
been tabulated in table 17. The results indicate that the organogels are highly 
hemocompatible in nature and indicating their probable biocompatibility [63]. 
Table 17: Results of hemocompatability test 
Sample % Hemolysis 
E 4.74 
I 1.58 
L 3.48 
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CHAPTER-O5 
CONCLUSION 
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5. Conclusion 
The current study deals with the development of span 80-tween 80 based organogels. The 
organogels were formed by fluid filled globular structures which aggregated to form a matrix 
system. The stability of the organogels was found to be dependent on the SM and water 
proportions. The in vitro release studies indicated that the organogels may be used as matrix 
for controlled delivery systems. The amorphousity of the organogels played an important role 
in governing the release rate of the drug from the matrices. The release kinetics study 
indicated Weibull release kinetics and a combination of Fickian and non-Fickian release 
behaviour. The higher the amorphousity, higher was the drug release from the gels. The 
preliminary study suggests that the organogels were preliminary found to be 
hemocompatible. The results indicate that the developed matrices may be used as a vehicle 
for controlled delivery system. 
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